Ratings Hospital Mater Dei S.A.

Equities

MATD3

BRMATDACNOR4

Delayed Sao Paulo 03:54:48 2024-06-14 pm EDT 5-day change 1st Jan Change
4.95 BRL -10.11% Intraday chart for Hospital Mater Dei S.A. -1.00% -40.72%

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Its low valuation, with P/E ratio at 8.54 and 6.23 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • Analyst opinion has improved significantly over the past four months.

Weaknesses

  • The company is in debt and has limited leeway for investment
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
-40.72% 341M -
-26.36% 15.04B
B+
-1.80% 11.9B
B
+3.65% 11.73B
B+
+8.83% 10.68B
B+
+26.35% 8.55B
B
-8.21% 7.35B
A-
+9.84% 6.48B
D
+19.81% 4.36B
B+
-4.42% 4.28B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. MATD3 Stock
  4. Ratings Hospital Mater Dei S.A.